|
|
Acquired long QT syndrome and monomorphic ventricular
tachycardia after alternative treatment with cesium chloride for brain cancer
Dalal AK, Harding JD, Verdino RJ
Department of Internal Medicine, Hospital of the University of Pennsylvania,
Philadelphia 19104, USA. dalala@uphs.upenn.edu
Individuals searching for symptomatic relief or a potential cure are
increasingly seeking and using nontraditional therapies for their various
diseases.
Little is known about the potential adverse effects that patients may
encounter while undergoing these alternative treatments.
Cesium chloride is an
unregulated agent that has been reported to have antineoplastic properties.
Cesium chloride is advertised as an alternative agent for many different types
of cancers and can be purchased easily on the Internet.
Recently, QT
prolongation and polymorphic ventricular tachycardia were reported in several
patients taking cesium chloride as alternative treatment for cancer.
We report
acquired QT prolongation and sustained monomorphic ventricular tachycardia in a
patient who self-initiated and completed a course of cesium chloride as
adjunctive treatment for brain cancer.
PMID: 15301336 [PubMed - indexed for MEDLINE]
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15301336
|
